Herriot Tabuteau Salary and Compensation - Axsome Therapeutics, Inc. CEO Salary 2025

In fiscal year 2025, Herriot Tabuteau, M.D. of Axsome Therapeutics, Inc. (AXSM), received total compensation of $10.3 million.

Herriot Tabuteau's compensation breakdown includes: base salary of $835K, stock awards valued at $5.5 million, option awards of $2.8 million, non-equity incentive compensation of $877K, and other compensation of $205K.

Compared to fiscal year 2024, Herriot Tabuteau's total compensation decreased 1% from $10.4 million to $10.3 million.

Axsome Therapeutics, Inc. (AXSM) Executive Pay 2025

Axsome Therapeutics, Inc.'s top 5 named executive officers received combined total compensation of $24.6 million in fiscal year 2025.

The named executive officers disclosed in Axsome Therapeutics, Inc.'s 2025 proxy statement are:Herriot Tabuteau (M.D.) with total compensation of $10.3 million, Mark Jacobson (M.A.) with total compensation of $4.2 million, Nick Pizzie (C.P.A., M.B.A.) with total compensation of $3.7 million, Hunter Murdock (Esq.) with total compensation of $3.2 million, and Ari Maizel (M.B.A.) with total compensation of $3.2 million.